학술논문
24-MONTH ANALYSIS OF CHANGE FROM BASELINE IN CLINICAL DEMENTIA RATING SCALE COGNITIVE AND FUNCTIONAL DOMAINS IN PRIME: A RANDOMIZED PHASE 1B STUDY OF THE ANTI–AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB
Document Type
Abstract
Author
Source
In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2018 14(7) Supplement:P242-P242
Subject
Language
ISSN
1552-5260